RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000071.xml
PDF herunterladen
Semin Neurol 2020; 40(06): 638-646
DOI: 10.1055/s-0040-1718720
DOI: 10.1055/s-0040-1718720
Review Article
Epilepsy—Work-Up and Management in Children
Abstract
Pediatric epilepsy is a highly variable condition due to age-related expression of syndromes that require specific diagnosis, evaluations, and treatments. Children with epilepsy differ from their adult counterparts in many important ways, mostly related to the age-related expression of specific epilepsy syndromes. This results in many important considerations related to the epilepsy diagnosis, classification, evaluations to determine an etiology, as well as treatment guidelines. A good understanding of these factors will help to establish an accurate epilepsy diagnosis, which in turn will guide appropriate testing and treatment decisions. In this way, patients will have improved seizure outcomes, and families will be educated appropriately and provided with the most accurate prognostic information available. The purpose of this article is to review the diagnosis, work-up, and management of pediatric epilepsy.
Publikationsverlauf
Artikel online veröffentlicht:
11. November 2020
© 2020. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Fisher RS, van Emde Boas W, Blume W. et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46 (04) 470-472
- 2 Villanueva V, Sánchez-Álvarez JC, Peña P, Puig JS, Caballero-Martínez F, Gil-Nagel A. Treatment initiation in epilepsy: an expert consensus in Spain. Epilepsy Behav 2010; 19 (03) 332-342
- 3 Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32 (04) 429-445
- 4
Fisher RS,
Acevedo C,
Arzimanoglou A.
et al.
ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;
55 (04) 475-482
MissingFormLabel
- 5 Kim LG, Johnson TL, Marson AG, Chadwick DW. MRC MESS Study group. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006; 5 (04) 317-322
- 6 Stroink H, Brouwer OF, Arts WF, Geerts AT, Peters AC, van Donselaar CA. The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. Dutch study of epilepsy in childhood. J Neurol Neurosurg Psychiatry 1998; 64 (05) 595-600
- 7 Shinnar S, Berg AT, Moshé SL. et al. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics 1990; 85 (06) 1076-1085
- 8
Berg AT,
Berkovic SF,
Brodie MJ.
et al.
Revised terminology and concepts for organization of seizures and epilepsies: report
of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;
51 (04) 676-685
MissingFormLabel
- 9 Sinclair DB, Snyder TJ. Corticosteroids for the treatment of Landau-kleffner syndrome and continuous spike-wave discharge during sleep. Pediatr Neurol 2005; 32 (05) 300-306
- 10 Hauptman JS, Salamon N, Mathern GW. Neuroimaging in the definition and organization of the epilepsies: we're not there yet. Epilepsia 2012; 53 (Suppl. 02) 22-27
- 11
Scheffer IE,
Berkovic S,
Capovilla G.
et al.
ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification
and Terminology. Epilepsia 2017; 58 (04) 512-521
MissingFormLabel
- 12 Blümcke I, Thom M, Aronica E. et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52 (01) 158-174
- 13 Linehan C, Tellez-Zenteno JF, Burneo JG, Berg AT. Future directions for epidemiology in epilepsy. Epilepsy Behav 2011; 22 (01) 112-117
- 14 Korff CM, Scheffer IE. Epilepsy classification: a cycle of evolution and revolution. Curr Opin Neurol 2013; 26 (02) 163-167
- 15 Tirosh E, Jaffe M, Dar H. The clinical significance of multiple hair whorls and their association with unusual dermatoglyphics and dysmorphic features in mentally retarded Israeli children. Eur J Pediatr 1987; 146 (06) 568-570
- 16 Fountain NB, Freeman JM. EEG is an essential clinical tool: pro and con. Epilepsia 2006; 47 (Suppl. 01) 23-25
- 17 Sansevere AJ, Avalone J, Strauss LD. et al. Diagnostic and therapeutic management of a first unprovoked seizure in children and adolescents with a focus on the revised diagnostic criteria for epilepsy. J Child Neurol 2017; 32 (08) 774-788
- 18 Binnie CD, Rowan AJ, Overweg J. et al. Telemetric EEG and video monitoring in epilepsy. Neurology 1981; 31 (03) 298-303
- 19 Theitler J, Dassa D, Gandelman-Marton R. The yield of non-elective inpatient video-EEG monitoring in adults. Neurol Sci 2017; 38 (06) 961-965
- 20 Bennett-Back O, Uliel-Siboni S, Kramer U. The yield of video-EEG telemetry evaluation for non-surgical candidate children. Eur J Paediatr Neurol 2016; 20 (06) 848-854
- 21 Lawley A, Evans S, Manfredonia F, Cavanna AE. The role of outpatient ambulatory electroencephalography in the diagnosis and management of adults with epilepsy or nonepileptic attack disorder: a systematic literature review. Epilepsy Behav 2015; 53: 26-30
- 22 Dash D, Hernandez-Ronquillo L, Moien-Afshari F, Tellez-Zenteno JF. Ambulatory EEG: a cost-effective alternative to inpatient video-EEG in adult patients. Epileptic Disord 2012; 14 (03) 290-297
- 23 Kandler R, Ponnusamy A, Wragg C. Video ambulatory EEG: a good alternative to inpatient video telemetry?. Seizure 2017; 47: 66-70
- 24 Goodwin E, Kandler RH, Alix JJ. The value of home video with ambulatory EEG: a prospective service review. Seizure 2014; 23 (06) 480-482
- 25 Syed TU, LaFrance Jr WC, Loddenkemper T. et al. Outcome of ambulatory video-EEG monitoring in a ã 10,000 patient nationwide cohort. Seizure 2019; 66: 104-111
- 26 Pittau F, Grouiller F, Spinelli L, Seeck M, Michel CM, Vulliemoz S. The role of functional neuroimaging in pre-surgical epilepsy evaluation. Front Neurol 2014; 5: 31
- 27 Zubler F, Seeck M, Landis T, Henry F, Lazeyras F. Contralateral medial temporal lobe damage in right but not left temporal lobe epilepsy: a (1)H magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry 2003; 74 (09) 1240-1244
- 28 deGrauw TJ, Salomons GS, Cecil KM. et al. Congenital creatine transporter deficiency. Neuropediatrics 2002; 33 (05) 232-238
- 29 Filippi CG, Uluğ AM, Deck MD, Zimmerman RD, Heier LA. Developmental delay in children: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2002; 23 (05) 882-888
- 30 Grodd W, Krägeloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991; 181 (01) 173-181
- 31 Tzika AA, Vajapeyam S, Barnes PD. Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations. AJNR Am J Neuroradiol 1997; 18 (02) 203-218
- 32 Ream MA, Mikati MA. Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study. Epilepsy Behav 2014; 37: 241-248
- 33 Sands TT, Choi H. Genetic testing in pediatric epilepsy. Curr Neurol Neurosci Rep 2017; 17 (05) 45
- 34 Ream MA, Patel AD. Obtaining genetic testing in pediatric epilepsy. Epilepsia 2015; 56 (10) 1505-1514
- 35 Lemke JR, Riesch E, Scheurenbrand T. et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012; 53 (08) 1387-1398
- 36
Soden SE,
Saunders CJ,
Willig LK.
et al.
Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis
of neurodevelopmental disorders. Sci Transl Med 2014; 6 (265) 265ra168
MissingFormLabel
- 37 Dixon-Salazar TJ, Silhavy JL, Udpa N. et al. Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med 2012; 4 (138) 138ra78
- 38 Sankar R. Initial treatment of epilepsy with antiepileptic drugs: pediatric issues. Neurology 2004; 63 (10) (Suppl. 04) S30-S39
- 39 Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy?. Epilepsia 1981; 22 (01) 1-10
- 40 Chadwick DW. Overuse of monitoring of blood concentrations of antiepileptic drugs. Br Med J (Clin Res Ed) 1987; 294 (6574): 723-724
- 41 Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991; 41 (07) 961-964
- 42 Lamberink HJ, Otte WM, Geerts AT. et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol 2017; 16 (07) 523-531
- 43
Kwan P,
Arzimanoglou A,
Berg AT.
et al.
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force
of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51 (06) 1069-1077
MissingFormLabel
- 44 Burneo JG, Shariff SZ, Liu K, Leonard S, Saposnik G, Garg AX. Disparities in surgery among patients with intractable epilepsy in a universal health system. Neurology 2016; 86 (01) 72-78
- 45 Reilly C, Atkinson P, Das KB. et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics 2014; 133 (06) e1586-e1593
- 46 Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012; 129 (02) 256-264
- 47 Guilfoyle SM, Follansbee-Junger K, Smith AW. et al. Antiepileptic drug behavioral side effects and baseline hyperactivity in children and adolescents with new onset epilepsy. Epilepsia 2018; 59 (01) 146-154
- 48 Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics 2001; 107 (01) 115-122
- 49 Kanner AM. Psychiatric comorbidities in new onset epilepsy: should they be always investigated?. Seizure 2017; 49: 79-82
- 50 Barry JJ, Ettinger AB, Friel P. Advisory Group of the Epilepsy Foundation as part of its Mood Disorder. et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008; 13 (Suppl. 01) S1-S29
- 51 Fountain NB, Van Ness PC, Bennett A. et al. Quality improvement in neurology: epilepsy update quality measurement set. Neurology 2015; 84 (14) 1483-1487
- 52 Kerr MP, Mensah S, Besag F. International League of Epilepsy (ILAE) Commission on the Neuropsychiatric Aspects of Epilepsy. et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52 (11) 2133-2138
- 53 Wilson SJ, Baxendale S, Barr W. et al. Indications and expectations for neuropsychological assessment in routine epilepsy care: report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017. Epilepsia 2015; 56 (05) 674-681
- 54 Wagner JL, Modi AC, Guilfoyle SM. et al. Current behavioral health and cognitive screening practices in pediatric epilepsy. Epilepsy Behav 2019; 101 (Pt A): 106214
- 55 Guilfoyle SM, Monahan S, Wesolowski C, Modi AC. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection. Epilepsy Behav 2015; 44: 5-10
- 56 Wagner JL, Guilfoyle SM, Rausch J, Modi AC. Psychometric validation of the Pediatric Symptom Checklist-17 in a pediatric population with epilepsy: a methods study. Epilepsy Behav 2015; 51: 112-116
- 57 Helmers SL, Kobau R, Sajatovic M. Centers for Disease Control and Prevention Managing Epilepsy Well Network. et al. Self-management in epilepsy: why and how you should incorporate self-management in your practice. Epilepsy Behav 2017; 68: 220-224
- 58 Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 1997; 38 (11) S6-S8
- 59 Devinsky O. Sudden, unexpected death in epilepsy. N Engl J Med 2011; 365 (19) 1801-1811
- 60 Annegers JF. United States perspective on definitions and classifications. Epilepsia 1997; 38 (11) S9-S12
- 61 Harden C, Tomson T, Gloss D. et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2017; 88 (17) 1674-1680
- 62 Ryvlin P, Nashef L, Lhatoo SD. et al. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol 2013; 12 (10) 966-977
- 63 Harden C, Tomson T, Gloss D. et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsy Curr 2017; 17 (03) 180-187
- 64 Xu Z, Ayyappan S, Seneviratne U. Sudden unexpected death in epilepsy (SUDEP): what do patients think?. Epilepsy Behav 2015; 42: 29-34
- 65 Morton B, Richardson A, Duncan S. Sudden unexpected death in epilepsy (SUDEP): don't ask, don't tell?. J Neurol Neurosurg Psychiatry 2006; 77 (02) 199-202
- 66 Cornet MC, Sands TT, Cilio MR. Neonatal epilepsies: clinical management. Semin Fetal Neonatal Med 2018; 23 (03) 204-212
- 67 Miceli F, Soldovieri MV, Ambrosino P. et al. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits. Proc Natl Acad Sci U S A 2013; 110 (11) 4386-4391
- 68 Shellhaas RA, Wusthoff CJ, Tsuchida TN. Neonatal Seizure Registry. et al. Profile of neonatal epilepsies: characteristics of a prospective US cohort. Neurology 2017; 89 (09) 893-899
- 69 Numis AL, Angriman M, Sullivan JE. et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014; 82 (04) 368-370
- 70 Bahi-Buisson N, Kaminska A, Boddaert N. et al. The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 2008; 49 (06) 1027-1037
- 71 Weeke LC, Brilstra E, Braun KP. et al. Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations. Eur J Paediatr Neurol 2017; 21 (02) 396-403
- 72 Barcia G, Fleming MR, Deligniere A. et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012; 44 (11) 1255-1259
- 73 Stamberger H, Nikanorova M, Willemsen MH. et al. STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology 2016; 86 (10) 954-962
- 74 Vilan A, Mendes Ribeiro J, Striano P. et al. A distinctive ictal amplitude-integrated electroencephalography pattern in newborns with neonatal epilepsy associated with KCNQ2 mutations. Neonatology 2017; 112 (04) 387-393
- 75 Bulteau C, Otsuki T, Delalande O. Epilepsy surgery for hemispheric syndromes in infants: hemimegalencepahly and hemispheric cortical dysplasia. Brain Dev 2013; 35 (08) 742-747
- 76 Chiron C, Dumas C, Jambaqué I, Mumford J, Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997; 26 (02) 389-395
- 77 Franz DN, Krueger DA. mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex. Am J Med Genet C Semin Med Genet 2018; 178 (03) 365-373
- 78 Ficicioglu C, Bearden D. Isolated neonatal seizures: when to suspect inborn errors of metabolism. Pediatr Neurol 2011; 45 (05) 283-291
- 79 Hernan AE, Holmes GL. Antiepileptic drug treatment strategies in neonatal epilepsy. Prog Brain Res 2016; 226: 179-193
- 80 Painter MJ, Scher MS, Stein AD. et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999; 341 (07) 485-489
- 81 Glauser TA, Cnaan A, Shinnar S. Childhood Absence Epilepsy Study Group. et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010; 362 (09) 790-799
- 82 Glauser TA, Cnaan A, Shinnar S. Childhood Absence Epilepsy Study Team. et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 2013; 54 (01) 141-155
- 83 Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993; 328 (01) 29-33
- 84 Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008; 70 (21) 1950-1958
- 85 Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamictal Lennox-Gastaut Study Group. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997; 337 (25) 1807-1812
- 86 Ng YT, Conry JA, Drummond R, Stolle J, Weinberg MA. OV-1012 Study Investigators. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology 2011; 77 (15) 1473-1481
- 87 Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. Topiramate YL Study Group. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999; 52 (09) 1882-1887
- 88 Gastaut H. Benign epilepsy of childhood with occipital paroxysms. In: Roger J, Dravet CH, Bureau M, Dreiffus FE, Wolf P. eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. London: John Libbey; 1985